Dawnrays Pharmaceutical (Holdings) Ltd is a major drug manufacturing company. The company operates two segments, including Intermediates and Bulk Medicines, and Finished Drugs. Most of its revenue is derived from the Finished Drugs segment. Nearly all of the company's sales are generated in Mainland China. It utilizes strategic partnerships as a component of its international strategies. The company is open to exploring potential acquisitions as a component of its overall growth strategy.